A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for Veterans With PTSD
1 other identifier
interventional
250
1 country
1
Brief Summary
Despite the availability of evidence-based treatments for PTSD, there are many challenges to successful trauma recovery for Veterans including difficulties starting and completing these treatments and gaps in fully addressing additional important treatment targets including lower social functioning and quality of life. Alternative, stand-alone treatment options that address a range of outcomes and can be easily accessed are needed to expand the reach of PTSD treatment to Veterans. One way to address this need is with a positive psychology intervention called MOVED, which has shown promise in a prior pilot study. MOVED is a web-based, self-guided intervention (8 sessions, 4 weeks) that uses moral elevation-feeling inspired by others' virtuous actions. This clinical trial will test if MOVED leads to decreased PTSD symptoms and increased social functioning and quality of life compared to a generic supportive treatment that does not focus on moral elevation. Results will help determine if MOVED is a useful alternative approach to target trauma recovery among Veterans with PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 23, 2025
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
Study Completion
Last participant's last visit for all outcomes
September 30, 2029
May 6, 2026
May 1, 2026
3.1 years
January 17, 2025
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
The CAPS-5 is a 30-item structured interview that will be used to assess clinician-rated PTSD symptom severity (range = 0-80).
Follow-up assessments at posttreatment, 3-months, and 6-months.
World Health Organization Quality of Life - Brief Version (WHOQOL-BREF)
The WHOQOL-BREF is a 26-item self-report measure that will be used to assess overall quality of life with 4 domains (physical health, psychological health, social relationships, and environment). Subscales scores are computed by summing all items for each subscale, then all scores are transformed to a range of 0-100. A higher score signifies higher or better quality of life.
Follow-up assessments at posttreatment, 3-months, and 6-months.
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
The WHODAS 2.0 is a self-report measures of functioning. Two socially-oriented subscales comprised of 13 items total will be used to assess social functioning across the Getting Along and Participation domains. Higher scores indicate greater functioning.
Follow-up assessments at posttreatment, 3-months, and 6-months.
Secondary Outcomes (5)
PTSD Checklist for DSM-5 (PCL-5)
Follow-up assessments at posttreatment, 3-months, and 6-months.
Moral Injury and Distress Scale (MIDS)
Follow-up assessments at posttreatment, 3-months, and 6-months.
Engagement with Beauty Scale (EBS) - Moral Beauty Subscale
Follow-up assessments at posttreatment, 3-months, and 6-months.
Purpose in Life - Short Form (PIL-SF)
Follow-up assessments at posttreatment, 3-months, and 6-months.
Posttraumatic Growth Inventory (PTGI)
Follow-up assessments at posttreatment, 3-months, and 6-months.
Other Outcomes (1)
State Moral Elevation Scale (SMES)
Administered during 8 sessions across 4 weeks
Study Arms (2)
MOVED
EXPERIMENTALMoral Elevation Online Intervention for Veterans Experiencing Distress.
Supportive Care Control
ACTIVE COMPARATORPresent-centered, nondirective intervention
Interventions
MOVED includes 8 self-guided, web-based sessions administered over 4 weeks. Web-based sessions include 3 core components: (1) elicit moral elevation, (2) engage in reflection about moral elevation response, and (3) set a behavioral goal that is inspired by the moral elevation exercise.
A present-centered, nondirective intervention that aims to control for the nonspecific therapeutic effects of supportive care. In this case, the effects of engaging in regular web-based sessions that convey information about PTSD symptoms. Sessions will include psychoeducation materials about PTSD symptoms, functioning, and resources for dealing with related stressors. Key components of MOVED will be strictly excluded.
Eligibility Criteria
You may qualify if:
- Enrolled in a VISN 17 health care system
- English-speaking and able to provide written informed consent
- Willingness to complete study procedures and be randomized
- Internet access and an electronic device to complete the web-based sessions
- Current diagnosis of PTSD based on the CAPS-5
- History of PTSD diagnosis for at least 1 year
You may not qualify if:
- History of severe traumatic brain injury indicated by medical record review and the Ohio State Traumatic Brain Injury Identification Method (OSU TBI-ID)
- Current psychosis or mania as indicated by medical record review and the Mini International Neuropsychiatric Interview (MINI)
- Current suicide risk based on the Beck Depression Inventory-II (BDI-II)
- Currently enrolled and actively participating in a trauma-focused treatment including:
- Cognitive Processing Therapy
- Prolonged Exposure
- Eye Movement Desensitization Reprocessing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central Texas Veterans Health Care System, Temple, TX
Temple, Texas, 76504-7451, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam P. McGuire, PhD
Central Texas Veterans Health Care System, Temple, TX
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- All staff conducting baseline and follow-up assessments (i.e., posttreatment, 3-months, 6-months) will be blinded to the assigned condition for all participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2025
First Posted
January 23, 2025
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
September 30, 2029
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 1 year after publication
A de-identified, anonymized dataset will be created and shared pursuant to a Data Use Agreement (DUA).